Drug Type Small molecule drug |
Synonyms |
Target |
Action blockers, inhibitors |
Mechanism CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers), PDE5A inhibitors(Phosphodiesterase 5A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Phase 2 | United States | - |